StemCells ! Günstig wie nie ....

Beiträge: 107
Zugriffe: 25.568 / Heute: 3
Microbot Medical 7,55 $ -2,20% Perf. seit Threadbeginn:   -99,94%
 
StemCells ! Günstig wie nie .... Chalifmann3
Chalifmann3:

StemCells ! Günstig wie nie ....

8
30.12.11 01:25
#1
StemCells, Inc. Announces World's First Neural Stem Cell Transplant in Spinal Cord Injury Patient

22 Sep 2011

StemCells announced that the first patient in the Company's breakthrough Phase I/II clinical trial in chronic spinal cord injury was successfully transplanted with the Company's proprietary HuCNS-SC(R) adult neural stem cells

NEWARK, CA, USA | September 22, 2011 | StemCells, Inc. (Nasdaq: STEM) announced today that the first patient in the Company's breakthrough Phase I/II clinical trial in chronic spinal cord injury was successfully transplanted with the Company's proprietary HuCNS-SC(R) adult neural stem cells. The stem cells were administered yesterday at Balgrist University Hospital, University of Zurich, a world leading medical center for spinal cord injury and rehabilitation. The transplant surgery was performed by a team of surgeons led by Dr. Raphael Guzman, a visiting staff neurosurgeon also on faculty at Department of Neurosurgery, Stanford University, and Dr. K. Min, an orthopedic surgeon at Balgrist University Hospital.

"I am pleased to be a part of this innovative clinical trial designed to help us assess the safety and potential efficacy of HuCNS-SC stem cells for spinal cord injury," explains Dr. Armin Curt, Principal Investigator. "The preclinical data underlying this trial provided compelling rationale to conduct a study of this nature in spinal cord-injured patients." StemCells, Inc. has published numerous preclinical studies demonstrating the therapeutic potential of the Company's human neural stem cells for the treatment of acute and chronic spinal cord injury. These studies were conducted in close collaboration with Drs. Aileen Anderson and Brian Cummings of the University of California, Irvine.

The first patient transplanted in the trial, a 23-year-old German man, suffered a spinal cord injury in an automobile accident in April of this year. He sustained a complete loss of sensation and mobility from the waist down. When asked about his decision to enroll in this leading-edge study, he said: "This terrible injury crossed out almost all my life plans, and has led me to an unexpected path. Participating in this clinical trial not only gives me a sense of hope, but it also helps move this important research forward."

"With this first patient enrolled and dosed, we remain on track to meet our goal of treating the first cohort of patients by the end of this year," said Stephen Huhn MD, FACS, FAAP, Vice President and Head of the CNS Program at StemCells, Inc. "While the trial's first cohort will consist of patients with the most severe, complete injury, the second and third cohorts will progress to patients with less severe, incomplete injury. This unique trial design will allow us to evaluate the potential of our HuCNS-SC cells as a treatment for a broad spectrum of spinal cord injury patients. Even a small improvement could have a marked impact on quality of life for the millions of people who suffer from this debilitating condition."

About the Clinical Trial

The Phase I/II clinical trial of StemCells, Inc.'s HuCNS-SC purified human adult neural stem cells is designed to assess both safety and preliminary efficacy. Twelve patients with thoracic (chest-level) neurological injuries at the T2-T11 level are planned for enrollment. The first three patients will all have injuries classified as ASIA A, in which there is no apparent neurological function below the injury level, the most severe level identified by the American Spinal Injury Association (ASIA) Impairment Scale. The second and third cohorts will be patients classified as ASIA B and ASIA C, those with less severe injury, in which there is some preservation of sensory or motor function. In addition to assessing safety, the trial will assess preliminary efficacy based on defined clinical endpoints, such as changes in sensation, motor and bowel/bladder function.

All patients will receive HuCNS-SC cells through direct transplantation into the spinal cord and will be temporarily immunosuppressed. Patients will be evaluated regularly in the post-transplant period in order to monitor and assess the safety of the HuCNS-SC cells, the surgery and the immunosuppression, as well as to measure any recovery of neurological function below the injury site. The Company intends to follow the effects of this therapy long-term, and a separate 4-year observational study will be initiated at the conclusion of this trial.

For information on patient enrollment, interested parties may contact the study nurse either by phone at +41 44 386 39 01, or by email at stemcells.pz@balgrist.ch.

Additional information about the Company's spinal cord injury program can be found on the StemCells, Inc. website at www.stemcellsinc.com/Therapeutic-Programs/Clinical-Trials.htm and at www.stemcellsinc.com/Therapeutic-Programs/...-Cord-Injury.htm, including video interviews with Company executives and independent collaborators.

About Chronic Spinal Cord Injury

According to a study reported by the Christopher and Dana Reeve Foundation, nearly 1.3 million people in the United States are estimated to be living with chronic spinal cord injury. The chronic phase of spinal cord injury is considered to begin when inflammation has stabilized and recovery has reached a plateau, which is typically several months following injury. Currently, there are no effective treatment options for patients with chronic spinal cord injury, and treatment approaches have generally targeted the acute and sub-acute time points, which are within hours or days of injury. Given the unmet need in chronic spinal cord injury, restoring some degree of function for patients at time points beyond the acute phase could have a transformative impact on the field. StemCells hopes to address a broad population of spinal cord-injured patients by opening the window of opportunity for therapeutic intervention well after the acute injury and targeting a wide range of injury levels and degrees of impairment.

MFG
Chali
81 Beiträge ausgeblendet.
Seite: Übersicht Alle 1 2 3 4 5


StemCells ! Günstig wie nie .... Balu4u
Balu4u:

Geile Sache wenn man 35 Stück kauft....

 
19.11.15 12:57
#83
StemCells ! Günstig wie nie .... Rudini
Rudini:

Im Bid 10k zu € 0,735

 
19.11.15 13:04
#84
StemCells ! Günstig wie nie .... Maecenas
Maecenas:

hier geht heute was

 
19.11.15 13:50
#85
premarket +62% und schon jetzt gutes volumen  
StemCells ! Günstig wie nie .... Kaulito
Kaulito:

hatte die schon abgeschrieben

 
19.11.15 14:14
#86
hoffe dass wir an knio anknüpfen können
StemCells ! Günstig wie nie .... Kaulito
Kaulito:

kbio meinte ich

 
19.11.15 14:15
#87
StemCells ! Günstig wie nie .... Insider86
Insider86:

rohrkrepierer

 
19.11.15 19:13
#88
offensichtlich
StemCells ! Günstig wie nie .... aktiengirl
aktiengirl:

gibts bad news? minus 30% heute...

 
09.03.16 18:29
#89
www.nasdaq.com/de/symbol/stem/real-time

ist noch jemand drin hier?
StemCells ! Günstig wie nie .... Chalifmann3
Chalifmann3:

nein

 
09.03.16 20:27
#90
nur das übliche bei stemcells: dilution,dilution,dilution ! Das wird noch jahrelang so weiter gehen,weil Stemcells nix in Phase 3 hat,deshlöab hab ich in der Vetrgangenheit auch nicht gekauft,und werde auch in den nächsten 5 Jahren nicht kaufwn,zwecklos !

Noch deutlich günstiger als Stemcells ist Cesca Therapeutics (KOOL),die hatten grad einen Reverse split und eine Phase 3 zu critcal limb ischemia steht an,interessant,würde ich kaufen ....

MFG
Chali
Der ARIVA.DE Newsletter
Bleiben Sie informiert mit dem
wöchentlichen Marktüberblick
von ARIVA.DE!
E-Mail-Adresse
Ich möchte Benachrichtigungen von ARIVA.DE erhalten.
Ja, ich habe die Datenschutzhinweise gelesen und akzeptiert (Pflichtfeld).
StemCells ! Günstig wie nie .... aktiengirl
aktiengirl:

Gegenbewegung nach starkem Abfall könnte losgehen,

 
14.03.16 16:20
#91
ich bin mit einem kleinen Zock mal eingestiegen..
www.nasdaq.com/de/symbol/stem/real-time
StemCells ! Günstig wie nie .... Kampfschwein300
Kampfschwei.:

Gibt es News oder

 
16.08.16 22:49
#92
Warum steigt die Aktie 500%?  
StemCells ! Günstig wie nie .... Pischaman
Pischaman:

Wahnsiinnnnnn ;)

 
16.08.16 22:55
#93
StemCells ! Günstig wie nie .... Rudini
Rudini:

Shortsqueze

 
16.08.16 22:56
#94
nach News, denke ich.

www.smarteranalyst.com/2016/08/16/...nnounce-strategic-merger/
StemCells ! Günstig wie nie .... Balu4u
Balu4u:

2,60 USD +2,23 USD +598,55 %

 
17.08.16 14:14
#95
Wünsche ich mir bei verastem auch :)  
StemCells ! Günstig wie nie .... Balu4u
Balu4u:

#91 Glückwunsch! Und jetzt raus?!

 
17.08.16 14:15
#96
StemCells ! Günstig wie nie .... wennichdaswueste
wennichdasw.:

nachbörslich $1,83 = sieht gut aus + 47,53 % UP

 
23.08.16 04:42
#97
www.nasdaq.com/de/symbol/stem/after-hours

www.nasdaq.com/de/symbol/stem/real-time
StemCells ! Günstig wie nie .... wennichdaswueste
wennichdasw.:

bin gespannt, ob heute nochmal 50% aufwärts geht ?

2
23.08.16 07:53
#98
StemCells ! Günstig wie nie .... digger2.0
digger2.0:

Ja, das wüsste ich auch gern!

 
23.08.16 13:25
#99
So wie es aussieht ist das so eine Art Manteldeal.
Microbot wird zur Tochter von Stemcells, um sich die Arbeit Kosten für den Börsengang zu sparen!
Wieviel die Kiste wert ist, hab ich allerdings noch nirgends gefunden.
StemCells ! Günstig wie nie .... digger2.0
digger2.0:

1,93 im Moment Premarket

 
23.08.16 13:31
Könnte wieder über die 2,50 klettern, wenn sie die 2,10 erstmal überwunden hat.
StemCells ! Günstig wie nie .... digger2.0
digger2.0:

Wieder News

 
20.11.16 18:17
und keine Kommentare hier? hmmm
Bis zum 28. soll der Merger über die Bühne gehen.....
StemCells ! Günstig wie nie .... Systema
Systema:

Oops, was ist mit Stemcells passiert?

 
14.01.17 14:15
Schaue nach längerer Zeit wieder rein und meine schöne Stemcells ist "weg"...
Gab es einen Reversesplit?  
StemCells ! Günstig wie nie .... Systema
Systema:

Ariva

 
14.01.17 14:18
29.11.16 Reverse Split 9:1
09.05.16 Reverse Split 12:1
StemCells ! Günstig wie nie .... wennichdaswueste
wennichdasw.:

gestern gab's 2 news hier , einmal hier

 
23.02.17 09:23
ih.advfn.com/p.php?pid=nmona&article=73922931
StemCells ! Günstig wie nie .... wennichdaswueste
wennichdasw.:

....... und einmal hier

 
23.02.17 09:23
ih.advfn.com/p.php?pid=nmona&article=73924997
StemCells ! Günstig wie nie .... oktay
oktay:

Weiss

 
12.08.17 08:57
Jemand was hier abgeht.
StemCells ! Günstig wie nie .... Systema

@oktay

 
Ich vermute das es eine Fusion gab, Stemcells wurde scheinbar von Microbot Medical Inc. übernommen bzw. mit denen verschmelzt, der Aktienchart von Stemcells ist geblieben. Was mich etwas abschreckt, sind die beiden Reversesplits in einem Jahr und trotzdem hat man wieder 34,81 Mio. Aktien am Markt (Quelle: Comdirect). Die Daten bei Ariva scheinen nicht mehr aktuell zu sein oder?  Laut Ariva: Aktienanzahl:  1,81 Mio. (Stand: 05.12.16). Vermutlich wieder verwässert, so etwas kotzt einen echt an an der Nasdaq, die geben den Aktienkursen gar keine Zeit mehr, normal sich zu entwickeln?

Seite: Übersicht Alle 1 2 3 4 5

Hot-Stocks-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem Microbot Medical Forum

  
Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
2 392 Microbot Medical übernimmt Stemcells - Neustart Systema Systema 13.01.21 06:09
8 106 StemCells ! Günstig wie nie .... Chalifmann3 Systema 28.08.17 04:42
  9 StemCells Inc. STEM - 90 zu 10 Chance ! Barica Investments Rudini 16.08.16 22:54
5 63 Stemcells aufpassen!!! soros snapple76 17.12.10 23:25
  2 Schaut euch mal StemCells an! Rajiva35 Rajiva35 03.04.06 19:55

--button_text--